11 – 20 of 38
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2008
-
Mark
Cognitive dysfunction 24-31 years after isolated optic neuritis.
(
- Contribution to journal › Article
-
Mark
Pathogenesis of autoimmune diseases: antibodies against transglutaminase, peptidylarginine deiminase and protein-bound citrulline in primary Sjögren's syndrome, multiple sclerosis and Alzheimer's disease.
(
- Contribution to journal › Article
- 2007
-
Mark
The role of MRI of the brain and spinal cord, and CSF examination for the diagnosis of primary progressive multiple sclerosis
(
- Contribution to journal › Article
-
Mark
A follow-up study of Nordic multiple sclerosis candidate gene regions
(
- Contribution to journal › Article
-
Mark
Health-related quality of life in secondary progressive multiple sclerosis
(
- Contribution to journal › Article
- 2006
-
Mark
Health-related quality of life in secondary progressive multiple sclerosis
(
- Contribution to journal › Published meeting abstract
-
Mark
Long-term subcutaneous interferon beta-1a therapy in patients with relapsing-remitting MS
(
- Contribution to journal › Article
- 2005
-
Mark
Interferon-beta1a treatment for multiple sclerosis.
(
- Contribution to journal › Article
-
Mark
Enhanced benefit of increasing interferon beta-1a dose and frequency in relapsing multiple sclerosis - The EVIDENCE study
(
- Contribution to journal › Article
-
Mark
Diagnostic criteria for multiple sclerosis: 2005 Revisions to the "McDonald Criteria"
(
- Contribution to journal › Article